The Use Of Daily Continuous Glucose Monitoring (Chmg) In Clinical Practice
Narbaev Abduhamid Namazovich , P.h.D. Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of Uzbekistan Togaeva Gulnora Siddiqovna , Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of Uzbekistan Davranova Aziza Davranovna , Assistant Department Of Internal Medicine With Endocrinology, Samarqand State Medical Institute,Samarqand, Republik Of UzbekistanAbstract
Type 1 diabetes mellitus is a disease in which the highest rates of premature mortality and early disability of patients are observed, which is caused by the onset of the disease at an early age, the instability of the course of type 1 diabetes and the threat of acute and chronic complications. The goals of type 1 diabetes mellitus treatment are its compensation, prevention of the risk of complications when normoglycemia is reached and stabilized.
Keywords
Diabetes mellitus, glucose
References
Ametov A. S. Prospects for the treatment of diabetes mellitus in the next 10 years. / Russian medical journal. -2005.-T. 13. Ne6. - P. 288-203
Ametov A.S., Avakova K.A .. An integrated approach to patient management, receiving insulin pump therapy. Russian Medical Journal. - 2007, vol. 15, No27, -C. 2050-2052
Balabolkin M.I., Petunina N.A., Telnova M.E., Klebanova E.M., Antonova K.V. "The role of insulin therapy in compensating for diabetes mellitus." // Russian Medical Journal. -2007, No25.-С.2-7.
Dedov II, Shestakova M.B. Algorithms for specialized medical care for patients with diabetes mellitus. Moscow, 2006
Tiselko A.V. Using a system of round-the-clock glucose monitoring and pump insulin therapy in patients with diabetes. Lecture, 2005, St. Petersburg.
American Diabetes Association. Continuous Subcutaneous Insulin Infusion. // Diabetes Care. -2005, Vol. 25, Suppl. 1.- P. 116
Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. // Am J Physiol Endocrinol Metab. 2007, N 278. E716-E728
Fiallo-Scharer R; Diabetes Research in Children Network Study Group: Eight-point glucose testing versus the continuous ghucose monitoring system in evaluation of glucemic control in type 1 diabetes. // J Clin Endocrinol Metab, No. 90.- P: 3387-3391, 2005
G. S. Togaeva, Clinical And Biochemical Parameters Of Patients With Type 2 Diabetes Who Were Trained At The School Of Self- Control. // JOURNAL OF BIOMEDICINE AND PRACTICE SPECIAL ISSUE-2. P-131-136, 2020
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.